Skip to main content
Caplight Logo









TransformativeMed

TransformativeMed

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.transformativemed.com/

Last Round

Series A

Extension

May 6, 2022

Est. Valuation

$18.2M

Total Funding Raised

$7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

TransformativeMed is a healthcare software company that provides an EHR-embedded platform to optimize clinical workflows and care team collaboration.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Workflow Automation, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

electronic health recordEHRclinical workflow automationclinical communicationhealthcare SaaSEHR integrationautonomous clinical agentsclinical decision supportagentic AIclinician burnout reductionAI scribehospital operationsdischarge planningAI agent securityvertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TransformativeMed Comparables

Compare TransformativeMed with similar companies based on industry and business-model similarity.

TransformativeMed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CareAlign
83%
Andor Health
74%
PerfectServe
73%

TransformativeMed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 6, 2022
Series AMay 7, 2019

Key People

Founding team and executive leadership

David Stone

CEO

Executive Team

TransformativeMed Investors

Notable investors and investment history

TransformativeMed investors
InvestorRounds
WRF CapitalSeries A
Alliance of AngelsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 94% MoM, reaching 1.5K.

  • Jan 21, 2026

    Monthly visitors grew 233% MoM.

TransformativeMed Filings

Explore SEC and related filing metadata, where available.

TransformativeMed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TransformativeMed's valuation, stock price, and market status.

Is TransformativeMed a public or private company?

TransformativeMed is a private company.

What is the current stock price of TransformativeMed?

TransformativeMed is a private company with no public stock price. No recent secondary market data is available.

How much is TransformativeMed worth (valuation)?

TransformativeMed's valuation is estimated at $18.2M based on funding round data.

Can I buy TransformativeMed stock?

TransformativeMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TransformativeMed's last funding round?

TransformativeMed's most recent funding round was Series A Extension on May 6, 2022.

Who are the main investors in TransformativeMed?

Key investors in TransformativeMed include Alliance of Angels.

Will TransformativeMed IPO soon?

No public IPO plans have been announced for TransformativeMed.

How can I track TransformativeMed secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TransformativeMed's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range17
Year Founded2010
Last FundingMay 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?